| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Discover the differences.
Providing more than just results.
Therapeutics testing covers a wide-range of areas from controlled substance monitoring to pharmacogenomics (PGx). We provide access to Mayo Clinic experts and a test menu developed through evidence-driven clinical innovation to help clinicians guide patient care.
Discover how the smallest differences can have the greatest impact. Let's find the right answers together.
By the numbers
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
190+
laboratory tests developed for our specialized therapeutics test menu
50+
years of research in pharmacogenomics
25M
tests performed
annually
24/7
support from Mayo Clinic physicians and scientists
An individualized approach
When PGx is incorporated into clinical practice, drug selection is enhanced with the genetic profile of individual patients, improving the clinician’s ability to avoid adverse drug reactions and maximize therapeutic efficacy.
Differences that matter
We understand that interpreting testing results can be tricky, so we provide health care providers with customized clinical guidance based on testing results.
Access to Mayo Clinic expertise
When you partner with Mayo Clinic Laboratories, you extend your network to include some of
the world’s leading genetic experts. Mayo Clinic clinicians, laboratorians, and genetic counselors are available to discuss testing options, interpret
results, or help with case review and coordination
Pain Managment Testing in the Opioid Crisis and Beyond
In this “Virtual Lecture,” Christine Snozek, Ph.D., discusses the opioid epidemic as it relates to pain management along with what changes have been made regarding regulations and laboratory support.
The Latest
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed CNS stimulant medications.
In this episode, Paul Jannetto, Ph.D., associate professor of laboratory medicine and pathology and director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab at Mayo Clinic, discusses how his three labs support toxicology testing for patient care.
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new comprehensive Controlled Substance Monitoring Panel, developed by the Clinical and Forensic Toxicology Laboratory at Mayo Clinic Laboratories, offers in-depth analysis on more than 70 different prescription medications and illicit substances to provide clinicians with details and interpretations on patients’ controlled substance use lacking in other laboratory assays.
PACE - In this month's "Virtual Lecture," Ann Moyer, M.D., Ph.D. describes how Pharmagenomic and therapeutic drug monitoring tools aid medical providers in selecting drugs and doses to maximize efficacy while minimizing toxicity for mental illnesses, including depression.
PACE - In this month’s “Virtual Lecture,” Christine Snozek, Ph.D. discusses the opioid epidemic as it relates to pain management along with what changes have been made regarding regulations and laboratory support.